Fulgent Genetics
FLGT
18 hedge funds and large institutions have $6.2M invested in Fulgent Genetics in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.
5.53% less ownership
Funds ownership: 13.48% → 7.94% (-5.5%)
14% less funds holding
Funds holding: 21 → 18 (-3)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
46% less capital invested
Capital invested by funds: $11.4M → $6.2M (-$5.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OWIM
Old West Investment Management
Los Angeles,
California
|
+$816K |
| 2 |
RA
Royce & Associates
New York
|
+$192K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$135K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$101K |
| 5 |
Morgan Stanley
New York
|
+$8.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.64M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$3.02M |
| 3 |
SC
Scholtz & Company
Stamford,
Connecticut
|
-$895K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$249K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$121K |
FLGT Hedge Fund Activity: Q4 2017 in Review
18 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2017, worth a combined $6.2M — down 46% from $11.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FLGT and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Old West Investment Management, opening a new position worth an estimated $816K. The largest seller was Wellington Management Group, exiting entirely with an estimated $3.64M sold.
- 18 institutional investors held Fulgent Genetics (FLGT) as of Q4 2017, down from 21 in Q3 2017.
- Funds reported $6.2M of Fulgent Genetics stock for Q4 2017, down 46% quarter-over-quarter.
- 4 funds opened new Fulgent Genetics positions in Q4 2017 and 7 closed out, a net change of -3 holders.
- The largest Fulgent Genetics buyer in Q4 2017 was Old West Investment Management, an estimated $816K added.
- The largest Fulgent Genetics seller in Q4 2017 was Wellington Management Group, an estimated $3.64M sold.
Based on aggregated 13F filings for Q4 2017.